Stay updated on Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2, replacing the previous revision.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No change to study details or page content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.2 was added, and a prior revision notice (v3.4.1) along with a government funding status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange DetectedAdded a government funding lapse notice about NIH operations and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedAdded a glossary toggle and updated QC metadata, including 'Last Update Submitted that Met QC Criteria' and a new 'Revision: v3.4.0'. The older label variants ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4') were removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Urothelial Cancer Clinical Trial page.